Plasminogen Activator Inhibitor 1 (PAI-1) Antigen

CPT: 85415
Print Share


  • PAI-1 Antigen

Expected Turnaround Time

4 - 8 days

Related Documents

For more information, please view the literature below.

Procedures for Hemostasis and Thrombosis: A Clinical Test Compendium

Specimen Requirements


Plasma, frozen


0.5 mL


Blue-top (sodium citrate) tube


Citrated plasma samples should be collected by double centrifugation. Platelet-poor plasma is needed. Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate.1 Evacuated collection tubes must be filled to completion to ensure a proper blood to anticoagulant ratio.2,3 The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples.4,5 When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternate anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Centrifuge for 10 minutes and carefully remove 2/3 of the plasma using a plastic transfer pipette, being careful not to disturb the cells. Deliver to a plastic transport tube, cap, and recentrifuge for 10 minutes. Use a second plastic pipette to remove the plasma, staying clear of the platelets at the bottom of the tube. Transfer the plasma into a LabCorp PP transpak frozen purple tube with screw cap (LabCorp N° 49482). Freeze immediately and maintain frozen until tested. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.

Please print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.

Storage Instructions


Patient Preparation

The patient should be in a resting state and the specimen collected in the morning to avoid diurnal variation of results.

Causes for Rejection

Hemolysis; clotted specimen; specimen contaminated with heparin (ie, drawn with blood gases); specimens containing fibrin clots; specimen thawed

Test Details


Measure the quantity of PAI-1 in plasma, which may be useful in the determination of PAI-1 deficiency.6


Samples containing platelets prior to freezing will give erroneously high results due to the release of latent PAI-1 from platelet granules.


Enzyme-linked immunosorbent assay (ELISA)

Additional Information

As PAI-1 is an acute phase reactant and also demonstrates diurnal variation, interpretation of results is difficult. Levels are highest in the morning. Deep vein thrombosis (DVT) and coronary artery disease (CAD) are associated with increased PAI-1 levels. Elevations have also been reported with diabetes mellitus, hypertension, obesity, insulin resistance, pregnancy, and with certain malignancies. Deficiency of PAI-1, an extremely rare and difficult diagnosis to make, has been associated with a bleeding diathesis. The PAI-1 antigen levels rise three- to sixfold during the third trimester of normal pregnancy. This is more pronounced in preëclamptic pregnancies. PAI-1 is the primary inhibitor of tissue plasminogen activator (tPA), a key enzyme in fibrinolysis. An increased plasma level of PAI-1 is associated with impaired fibrinolytic function. PAI-1 is found in several forms: active, inactive (latent), and complexed to tPA and urokinase plasminogen activator (uPA), all of which are measured in the PAI-1 antigen assay.


1. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol. 1997 Jan; 107(1):105-110.8980376
2. Reneke J, Etzell J, Leslie S, Ng VL, Gottfried EL. Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol. 1998 Jun; 109(6):754-757.9620035
3. National Committee for Clinical Laboratory Standardization. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays; Approved Guideline. 5th ed. Villanova, Pa: NCCLS; 2008. Document H21-A5:28(5).
4. Gottfried EL, Adachi MM. Prothrombin time and activated partial thromboplastin time can be performed on the first tube. Am J Clin Pathol. 1997 Jun; 107(6):681-683. 9169665
5. McGlasson DL, More L, Best HA, Norris WL, Doe RH, Ray H. Drawing specimens for coagulation testing: Is a second tube necessary? Clin Lab Sci. 1999 May-Jun; 12(3):137-139. 10539100
6. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995 Oct; 74(4):1185-1190.8560433


Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
500057 PAI-1 Antigen 500059 PAI-1 Antigen ng/mL 22758-7

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at Additional information regarding LOINC® codes can be found at, including the LOINC Manual, which can be downloaded at